Results 111 to 120 of about 79,096 (221)
Urokinase Receptor and Vascular Endothelial Growth Factor Are Synergistically Associated with the Liver Metastasis of Colorectal Cancer [PDF]
Hiroyuki Konno +10 more
openalex +1 more source
This visual summary illustrates the key findings of the study on core decompression (CD) combined with superselective intra‐arterial embolization (SIAE) for osteonecrosis of the femoral head (ONFH). The top‐left panel shows the dual surgical techniques targeting the necrotic femoral head.
Li Qian +6 more
wiley +1 more source
Soluble urokinase-type plasminogen activator receptor (suPAR) strongly predicts outcomes and incident chronic kidney disease (CKD) in patients with cardiovascular disease (CVD). Whether the association between suPAR and CKD is a reflection of its overall
Salim S. Hayek +11 more
doaj +1 more source
Kidney cell electrophoresis [PDF]
A kidney cell electrophoresis technique is described in four parts: (1) the development and testing of electrophoresis solutions; (2) optimization of freezing and thawing; (3) procedures for evaluation of separated kidney cells; and (4) electrophoretic ...
Todd, P.
core +1 more source
Intravenous Thrombolysis for Minor Acute Ischemic Stroke
Academic Emergency Medicine, EarlyView.
Brit Long, Michael Gottlieb
wiley +1 more source
Abstract figure legend Excessive hypercholesterolaemia during pregnancy impairs maternal endothelial function, which, in turn, drives the development of pre‐eclampsia and may also contribute to the increased risk of later‐life cardiovascular disease in women.
Amanda A. de Oliveira +3 more
wiley +1 more source
Objective A cardiovascular safety issue has been associated with JAK inhibitors (JAKi). This study compares the effects of distinct approved JAKi on endothelial cell (EC) dysfunction and apoptosis during inflammation. Methods Massive inflammation was induced in human vascular ECs by tumor necrosis factor (TNF) with interleukin‐17A (IL‐17A) treated or ...
Aliki Zavoriti, Pierre Miossec
wiley +1 more source
Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients [PDF]
In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Patients' ages ranged from 2 to 12 years. Urokinase (dosage: 3,100 IU/kg/day) was diluted in normal saline to produce 1000 IU/ml (maximum dosage 100,000 IU ...
Bergamini, Barbara Maria +6 more
core
Probing Cholesterol-Dependence of Integrin-Urokinase Receptor Complex Formation using Confocal Dual-Color Fluorescence Intensity Analysis [PDF]
Yifan Ge +3 more
openalex +1 more source

